TTrialPathMatch Me to Trials
← Back to trials
RecruitingSpinal Cord Injuries (SCI)

Dose Optimization Study of Acute Intermittent Hypoxia in Spinal Cord Injury

Eligible age

18–75 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study aims to evaluate how different doses of acute intermittent hypoxia (AIH) affect lower-limb strength, reaction time, and responsiveness in individuals with spinal cord injury (SCI). The objective is to identify the dose that most effectively improves motor output while also examining parameters that may account for variability in response.

Sponsor: Milap Sandhu

You may qualify if…

  • Chronic Spinal Cord Injury (\>6 months)
  • Motor incomplete SCI classified as AIS C or D
  • Volitional ankle plantarflexion strength in at least one leg

You may not qualify if…

  • Uncontrolled hypertension (outside 140/90 and 90/60)
  • Concurrent medical illness
  • Traumatic brain injury
  • Cardiovascular complications
  • Pulmonary complications
  • Metabolic dysfunction
  • Continued use of anti-spasticity medications
  • Previously diagnosed obstructive sleep apnea

Where it's recruiting

Illinois

Chicago

Source: ClinicalTrials.gov · NCT07739992 · last updated 2026-07-31

Dose Optimization Study of Acute Intermittent Hypoxia in Spinal Cord I · TrialPath